Tuesday, July 28, 2026
Live
Corporate

Revance Therapeutics Leadership Changes

 Effective October 1, 2025, Kira Schwartz joined as Chief Legal Officer, and Nick Crowe was promoted to Chief Operating Officer. This reshuffle aims to bolster legal and operational strategies amid market volatility.  

By Whispers in the Corridors 1 min read

 Effective October 1, 2025, Kira Schwartz joined as Chief Legal Officer, and Nick Crowe was promoted to Chief Operating Officer. This reshuffle aims to bolster legal and operational strategies amid market volatility.

 

Share

Comments (0)

Comments are moderated before they appear.

No comments yet. Be the first.